An Escherichia coli mutant with a disrupted visA gene was defective in ferrochelatase activity but expressed wild-type levels of protoporphyrinogen oxidase activity. The visA coding region was placed under the transcriptional control of T7 RNA polymerase in an E. coli expression system, and the product was expressed as a 38-kDa protein. The overexpressed protein was purified to near homogeneity and was found to contain ferrochelatase activity. The data show that the visA gene encodes ferrochelatase, and we propose that it be renamed hemH to reflect that conclusion.
Heme is the prosthetic group of cytochromes, hemoglobins, and other respiratory enzymes, and precursors of the heme synthesis pathway are also used for synthesis of chlorophylls, corrins, and bilins in organisms that express them. In Eschenchia coli, heme synthesis from glutamyltRNA requires nine enzymatic steps, and the genes that encode the first five enzymes have been isolated and the nucleotide sequences have been determined (1, 3, 7, 8, 11-14, 16-19, 27, 30, 31) . By contrast, much less genetic information is available concerning the genes involved in the late steps of heme synthesis in E. coli; mutants were obtained that are reported to be deficient in a late heme synthesis enzyme activity or were predicted to be so on the basis of some other phenotype (6, 24, 26) . However, the genes disrupted in those mutants have not been described and those strains are no longer available for experimentation (5) . Among the lost strains was a pop-l locus mutant; the suggestion that the ferrochelatase gene is located at that locus was put forth (6), but it has never been demonstrated. Recently, E. coli mutants were isolated on the basis of sensitivity to visible light, and a considerable body of indirect evidence suggests that the defective gene, designated visA, is involved in a late step in heme synthesis (20, 21, 23 Strain AVis contained a wild-type level of protoporphyrinogen oxidase activity, but no ferrochelatase activity was detected in that mutant ( Table 1 ). The visA gene was amplified from strain TB1 genomic DNA by the polymerase chain reaction and cloned into pBluescript IIKS+ for construction of pVisA3. pVisA3 conferred hemin prototrophy and loss of the fluorescent-colony phenotype on the mutant, and the transformant expressed a very high level of ferrochelatase activity compared with visA + strain TB1 (Table 1 ). These data show that visA is essential for ferrochelatase activity and that protoporphyrinogen oxidase activity is affected neither by the visA deletion nor by the presence of the gene in a high copy number. The high level of ferrochelatase activity expressed in AVis(pVisA3) indicates either that visA encodes that enzyme or that it encodes a protein involved in its expression.
Characterization of the visA gene product. The visA gene was modified at the 5' end of the coding region by using the polymerase chain reaction such that it could be cloned into the NdeI-BamHI sites of pET3c and express authentic protein (Fig. 1A) . This plasmid construct, designated pETVISA, allows the visA gene to be under the transcriptional control of T7 RNA polymerase when placed into E. coli BL21(DE3)(pLysS) (25) . Strain BL21(DE3)(pLysS) (pETVISA) cells induced for expression of the plasmidborne visA gene synthesized a peptide of approximately 38 kDa that was easily discerned on sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) gels stained with Coomassie blue (Fig. 1B) . This peptide was somewhat larger than the 36-kDa protein predicted by the putative amino acid sequence of the visA gene product (20) , and it was absent in protein from the control strain (Fig. 1B) scripts in strain BL21(DE3)(pLysS)(pETVISA) in the presence of that antibiotic. Labeling of cellular protein with [35S]methionine after addition of rifampin showed that only the overexpressed 38-kDa protein was radiolabeled (Fig.  1B) . This finding demonstrated that the overexpressed protein observed in the Coomassie blue-stained gel is the visA gene product and not a peptide encoded by a chromosomal gene which has been induced by expression of visA.
Much of the overexpressed visA product aggregated into presumptive inclusion bodies ( Fig. 2A) , as is common for proteins overexpressed in E. coli (2) . This insoluble fraction was nearly homogeneous for the visA product, as observed on SDS-PAGE gels ( Fig. 2A) , thus providing a one-step purification scheme. The purified protein possessed ferrochelatase activity ( conferred hemin prototrophy on strain AVis, and the colonies of those transformants were not fluorescent under UV light. Cell extracts of the transformants contained ferrochelatase activities of 13 and 1.2 nmol of mesoheme formed per h per mg of protein for the yeast and mouse enzymes, respectively. Human ferrochelatase has also been expressed in E. coli (4) . The functional complementation of strain AVis with ferrochelatase-encoding mouse and yeast DNAs described herein shows that the eukaryotic proteins not only contained an activity in E. coli but must also function in concert with the E. coli heme enzymes for heme synthesis. This conclusion is particularly relevant in the context of the proposed substrate channeling between ferrochelatase and protoporphyrinogen oxidase (9) , which would require at least dynamic protein-protein interactions, if not stable complex formation. Therefore, it will be interesting to learn the nature of the interactions between the heterologous enzymes in transformed AVis cells. A ferrochelatase-protoporphyrinogen oxidase complex has also been proposed to explain the diminution of both enzyme activities in humans with a defect in the structural gene for ferrochelatase (9, 22, 28 2) and autoradiogram (lanes 3 and 4) of SDS-PAGE gels of total cell proteins of BL21(DE3)(pLysS)(pETVISA) (lanes 2 and 4) and BL21(DE3)(pLysS)(pET3c) (lanes 1 and 3) . The numbers on the left are molecular sizes in kilodaltons.
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